JG
FATE icon

Jefferies Group’s Fate Therapeutics FATE Stock Holding History

Jefferies Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,100
Closed -$1.33M – 1762
2021
Q1 		$1.33M Buy
+16,100
New +$1.54M 0.01% 813
2020
Q1 		– Sell
-54,729
Closed -$1.07M – 2222
2019
Q4 		$1.07M Buy
54,729
+29,142
+114% +$463K 0.01% 1425
2019
Q3 		$397K Buy
+25,587
New +$490K ﹤0.01% 2011

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jefferies Group's FATE Position: Q2 2021 in Review

Jefferies Group sold out of Fate Therapeutics (FATE) in Q2 2021, closing a stake of 16,100 shares — an estimated $1.33M sold.

Jefferies Group first reported a position in FATE in Q3 2019 and held it in 3 quarters. The position peaked at $1.33M in Q1 2021. 272 funds tracked by Wall St. Rank hold FATE as of Q2 2021.

  • Jefferies Group reported no remaining Fate Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 16,100 Fate Therapeutics shares in Q2 2021, an estimated $1.33M.
  • Jefferies Group first reported a position in Fate Therapeutics in Q3 2019 and held it in 3 quarters.
  • Jefferies Group's Fate Therapeutics position peaked at $1.33M in Q1 2021.
  • 272 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.